Literature DB >> 24004692

Reversible, irreversible and effective transverse relaxation rates in normal aging brain at 3T.

J Sedlacik1, K Boelmans, U Löbel, B Holst, S Siemonsen, J Fiehler.   

Abstract

Quantitative transverse relaxation rates in normal aging brain are essential to investigate pathologies associated with iron accumulation and tissue degeneration. Since absolute values depend on imaging methods and magnetic field strengths, continuous evaluation of specific reference values remains requisite. Multi-echo turbo spin echo and multi-echo gradient recalled echo imaging sequences were applied to 66 healthy subjects (18-84years) at 3T to quantify the irreversible (R2), effective (R2*) and reversible (R2'=R2*-R2) transverse relaxation rates. Representative regions-of-interest (ROIs) were determined automatically in gray matter (GM) and white matter (WM) on T1-weighted scans. Phantom experiments of different sized iron-oxide particles were conducted to explore the correlation of R2' related to R2 for the evaluation of the size of iron deposits. R2 decreased with age for the majority of ROIs, but increased for putamen, head of caudate nucleus and nucleus accumbens. R2* and R2' increased with age in deep GM structures except for the thalamus. R2* and R2' showed a distinct dependency on fiber orientation in exemplary WM regions. R2', R2 and R2* were strongly linear proportional to age-related iron content in deep GM with slopes of 0.88, 0.18 and 1.08 in [1/s/mg Fe per 100g wet tissue] and intercepts of 1.69, 9.25 and 10.69 in [1/s], respectively. Linear and non-linear curve fitting of R2' vs. R2 in phantoms revealed increased slopes with increasing particle size. In vivo, averaged R2' vs. R2 data points of patients with Parkinson's disease and progressive supranuclear palsy were above the fitted curves of healthy subjects suggesting larger sized iron deposits in these neurodegenerative diseases. Decreased R2 with age may reflect physiological tissue degeneration, whereas increased R2* and R2' with age most likely denote physiological iron accumulation. The low intercept of R2' vs. iron content suggests a nearly sole sensitivity of R2' to iron in deep GM, potentially allowing a more specific estimation of the iron content than R2 or R2*. Since R2* and R2' depend on the fiber orientation, their feasibility to estimate iron content in WM is challenging. The analysis of R2' related to R2 may provide valuable information about the size of iron deposits.
© 2013.

Entities:  

Keywords:  GESFIDE; GESSE; Iron; PSP; Particle size; Quantification; R2; R2'; R2*; T2'; gradient echo sampled spin echo; gradient-echo sampling of free induction decay and echo; mGRE; mTSE; multi-echo gradient recalled echo; multi-echo turbo spin echo; progressive supranuclear palsy; rate of effective transverse relaxation; rate of irreversible transverse relaxation; rate of reversible transverse relaxation

Mesh:

Year:  2013        PMID: 24004692     DOI: 10.1016/j.neuroimage.2013.08.051

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  32 in total

1.  Longitudinal Development of Brain Iron Is Linked to Cognition in Youth.

Authors:  Bart Larsen; Josiane Bourque; Tyler M Moore; Azeez Adebimpe; Monica E Calkins; Mark A Elliott; Ruben C Gur; Raquel E Gur; Paul J Moberg; David R Roalf; Kosha Ruparel; Bruce I Turetsky; Simon N Vandekar; Daniel H Wolf; Russell T Shinohara; Theodore D Satterthwaite
Journal:  J Neurosci       Date:  2020-01-27       Impact factor: 6.167

2.  Upper brainstem GABA levels in Parkinson's disease.

Authors:  Yulu Song; Tao Gong; Muhammad G Saleh; Mark Mikkelsen; Guangbin Wang; Richard A E Edden
Journal:  MAGMA       Date:  2021-03-20       Impact factor: 2.310

3.  Comparison of R2' measurement methods in the normal brain at 3 Tesla.

Authors:  Wendy Ni; Thomas Christen; Zungho Zun; Greg Zaharchuk
Journal:  Magn Reson Med       Date:  2014-04-18       Impact factor: 4.668

4.  Evaluation of brain ageing: a quantitative longitudinal MRI study over 7 years.

Authors:  René-Maxime Gracien; Lucas Nürnberger; Pavel Hok; Stephanie-Michelle Hof; Sarah C Reitz; Udo Rüb; Helmuth Steinmetz; Rüdiger Hilker-Roggendorf; Johannes C Klein; Ralf Deichmann; Simon Baudrexel
Journal:  Eur Radiol       Date:  2016-07-05       Impact factor: 5.315

5.  Separation of cellular and BOLD contributions to T2* signal relaxation.

Authors:  Xialing Ulrich; Dmitriy A Yablonskiy
Journal:  Magn Reson Med       Date:  2015-03-10       Impact factor: 4.668

6.  Age-related differences in GABA levels are driven by bulk tissue changes.

Authors:  Celine Maes; Lize Hermans; Lisa Pauwels; Sima Chalavi; Inge Leunissen; Oron Levin; Koen Cuypers; Ronald Peeters; Stefan Sunaert; Dante Mantini; Nicolaas A J Puts; Richard A E Edden; Stephan P Swinnen
Journal:  Hum Brain Mapp       Date:  2018-05-02       Impact factor: 5.038

7.  Visualization of Nigrosome 1 from the Viewpoint of Anatomic Structure.

Authors:  N Arai; H Kan; M Ogawa; Y Uchida; M Takizawa; K Omori; T Miyati; H Kasai; H Kunitomo; Y Shibamoto
Journal:  AJNR Am J Neuroradiol       Date:  2019-12-05       Impact factor: 3.825

8.  The relationship between blood flow impairment and oxygen depletion in acute ischemic stroke imaged with magnetic resonance imaging.

Authors:  Alexander Seiler; Nicholas P Blockley; Ralf Deichmann; Ulrike Nöth; Oliver C Singer; Michael A Chappell; Johannes C Klein; Marlies Wagner
Journal:  J Cereb Blood Flow Metab       Date:  2017-09-20       Impact factor: 6.200

9.  Dentate nucleus iron deposition is a potential biomarker for tremor-dominant Parkinson's disease.

Authors:  Naying He; Pei Huang; Huawei Ling; Jason Langley; Chunlei Liu; Bei Ding; Juan Huang; Hongmin Xu; Yong Zhang; Zhongping Zhang; Xiaoping Hu; Shengdi Chen; Fuhua Yan
Journal:  NMR Biomed       Date:  2016-05-18       Impact factor: 4.044

10.  On the relationship between cellular and hemodynamic properties of the human brain cortex throughout adult lifespan.

Authors:  Yue Zhao; Jie Wen; Anne H Cross; Dmitriy A Yablonskiy
Journal:  Neuroimage       Date:  2016-03-17       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.